相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comparison of clinical outcomes in PPMS in the INFORMS original trial data set
Marcus W. Koch et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
Marcus W. Koch et al.
NEUROLOGY (2021)
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets
Marcus W. Koch et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Nine Hole Peg Test asymmetry in refining upper limb assessment in multiple sclerosis
C. Solaro et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis
Claudio Solaro et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Raja Kapoor et al.
LANCET NEUROLOGY (2018)
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
Peter Feys et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
Robert W. Motl et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
Peter Feys et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
Robert W. Motl et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Comparative utility of disability progression measures in PPMS Analysis of the PROMiSe data set
Marcus W. Koch et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Disability as an outcome in MS clinical trials
G. C. Ebers et al.
NEUROLOGY (2008)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
J. J. Kragt et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite
ELJ Hoogervorst et al.
MULTIPLE SCLEROSIS (2004)
Quantitative functional measures in MS: What is a reliable change?
SR Schwid et al.
NEUROLOGY (2002)
分享论文
